Biotage AB (publ) (BIOT.ST)
SEK 158.8
(1.73%)
SEK 158.8
(1.73%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 376 Million SEK | -3.98% |
| 2022 | 327 Million SEK | 20.66% |
| 2021 | 271 Million SEK | 31.44% |
| 2020 | 206.18 Million SEK | -0.93% |
| 2019 | 208.12 Million SEK | 20.66% |
| 2018 | 172.47 Million SEK | 29.07% |
| 2017 | 133.63 Million SEK | 34.82% |
| 2016 | 99.11 Million SEK | 32.53% |
| 2015 | 74.78 Million SEK | 51.66% |
| 2014 | 49.31 Million SEK | 25.81% |
| 2013 | 39.19 Million SEK | -10.61% |
| 2012 | 43.84 Million SEK | 74.86% |
| 2011 | 25.07 Million SEK | 105.99% |
| 2010 | -418.76 Million SEK | -4036.72% |
| 2009 | -10.12 Million SEK | -145.0% |
| 2008 | 22.49 Million SEK | -47.59% |
| 2007 | 42.92 Million SEK | 564.13% |
| 2006 | 6.46 Million SEK | 110.27% |
| 2005 | -62.94 Million SEK | -3.75% |
| 2004 | -60.67 Million SEK | 76.77% |
| 2003 | -261.18 Million SEK | -51.28% |
| 2002 | -172.64 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 65 Million SEK | -22.62% |
| 2024 Q2 | 84 Million SEK | 10.53% |
| 2024 Q1 | 76 Million SEK | -50.0% |
| 2023 Q1 | 54 Million SEK | -20.59% |
| 2023 FY | 376 Million SEK | 14.98% |
| 2023 Q3 | 65 Million SEK | 25.0% |
| 2023 Q2 | 52 Million SEK | -3.7% |
| 2023 Q4 | 152 Million SEK | 133.85% |
| 2022 Q3 | 97 Million SEK | 4.3% |
| 2022 FY | 327 Million SEK | 20.66% |
| 2022 Q1 | 96 Million SEK | 57.38% |
| 2022 Q2 | 93 Million SEK | -3.13% |
| 2022 Q4 | 68 Million SEK | -29.9% |
| 2021 FY | 271 Million SEK | 31.44% |
| 2021 Q1 | 79.37 Million SEK | 33.16% |
| 2021 Q2 | 62.51 Million SEK | -21.24% |
| 2021 Q4 | 61 Million SEK | -10.29% |
| 2021 Q3 | 68 Million SEK | 8.77% |
| 2020 Q1 | 61.39 Million SEK | 62.16% |
| 2020 FY | 206.18 Million SEK | -0.93% |
| 2020 Q4 | 59.61 Million SEK | -1.78% |
| 2020 Q3 | 60.69 Million SEK | 147.89% |
| 2020 Q2 | 24.48 Million SEK | -60.12% |
| 2019 FY | 208.12 Million SEK | 20.66% |
| 2019 Q3 | 64.33 Million SEK | 14.71% |
| 2019 Q2 | 56.08 Million SEK | 12.51% |
| 2019 Q1 | 49.84 Million SEK | 39.48% |
| 2019 Q4 | 37.86 Million SEK | -41.15% |
| 2018 Q1 | 41.59 Million SEK | 73.85% |
| 2018 FY | 172.47 Million SEK | 29.07% |
| 2018 Q2 | 50.01 Million SEK | 20.24% |
| 2018 Q3 | 45.13 Million SEK | -9.74% |
| 2018 Q4 | 35.73 Million SEK | -20.83% |
| 2017 Q3 | 29.25 Million SEK | -21.33% |
| 2017 Q1 | 34.94 Million SEK | 45.12% |
| 2017 Q2 | 37.19 Million SEK | 6.42% |
| 2017 FY | 133.63 Million SEK | 34.82% |
| 2017 Q4 | 23.92 Million SEK | -18.24% |
| 2016 Q4 | 24.08 Million SEK | -11.57% |
| 2016 FY | 99.11 Million SEK | 32.53% |
| 2016 Q2 | 24.22 Million SEK | 2.76% |
| 2016 Q1 | 23.57 Million SEK | 16.97% |
| 2016 Q3 | 27.23 Million SEK | 12.41% |
| 2015 FY | 74.78 Million SEK | 51.66% |
| 2015 Q4 | 20.15 Million SEK | 6.21% |
| 2015 Q3 | 18.97 Million SEK | 7.18% |
| 2015 Q2 | 17.7 Million SEK | -1.38% |
| 2015 Q1 | 17.95 Million SEK | 30.95% |
| 2014 FY | 49.31 Million SEK | 25.81% |
| 2014 Q2 | 13.54 Million SEK | 43.16% |
| 2014 Q3 | 12.59 Million SEK | -7.07% |
| 2014 Q1 | 9.46 Million SEK | -29.6% |
| 2014 Q4 | 13.7 Million SEK | 8.88% |
| 2013 Q3 | 7.61 Million SEK | -36.93% |
| 2013 FY | 39.19 Million SEK | -10.61% |
| 2013 Q1 | 6.07 Million SEK | -55.05% |
| 2013 Q2 | 12.06 Million SEK | 98.55% |
| 2013 Q4 | 13.44 Million SEK | 76.65% |
| 2012 Q4 | 13.51 Million SEK | 52.32% |
| 2012 Q3 | 8.87 Million SEK | -31.02% |
| 2012 Q1 | 8.58 Million SEK | -12.42% |
| 2012 Q2 | 12.86 Million SEK | 49.81% |
| 2012 FY | 43.84 Million SEK | 74.86% |
| 2011 FY | 25.07 Million SEK | 105.99% |
| 2011 Q2 | 1.75 Million SEK | -32.5% |
| 2011 Q3 | 10.91 Million SEK | 521.94% |
| 2011 Q4 | 9.8 Million SEK | -10.16% |
| 2011 Q1 | 2.6 Million SEK | 100.6% |
| 2010 Q3 | 4.84 Million SEK | -36.55% |
| 2010 Q2 | 7.63 Million SEK | 64.75% |
| 2010 Q1 | 4.63 Million SEK | 29.85% |
| 2010 FY | -418.76 Million SEK | -4036.72% |
| 2010 Q4 | -435.86 Million SEK | -9099.98% |
| 2009 Q2 | 5.97 Million SEK | 127.55% |
| 2009 Q4 | 3.56 Million SEK | 76.46% |
| 2009 Q1 | -21.68 Million SEK | 0.0% |
| 2009 FY | -10.12 Million SEK | -145.0% |
| 2009 Q3 | 2.02 Million SEK | -66.16% |
| 2008 FY | 22.49 Million SEK | -47.59% |
| 2007 FY | 42.92 Million SEK | 564.13% |
| 2006 FY | 6.46 Million SEK | 110.27% |
| 2005 FY | -62.94 Million SEK | -3.75% |
| 2004 FY | -60.67 Million SEK | 76.77% |
| 2003 FY | -261.18 Million SEK | -51.28% |
| 2002 FY | -172.64 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AddLife AB (publ) | 585 Million SEK | 35.726% |
| Bonesupport Holding AB (publ) | 13.93 Million SEK | -2599.21% |
| Doxa AB (publ) | 269.4 Million SEK | -39.569% |
| Elekta AB (publ) | 2.03 Billion SEK | 81.56% |
| iZafe Group AB (publ) | -35.63 Million SEK | 1155.142% |
| Ortivus AB (publ) | -17.61 Million SEK | 2234.908% |
| Ortivus AB (publ) | -17.61 Million SEK | 2234.908% |
| Q-linea AB (publ) | -230.58 Million SEK | 263.062% |
| S2Medical AB (publ) | -15.26 Million SEK | 2563.334% |
| Synsam AB (publ) | 696 Million SEK | 45.977% |